# Filing Detail

Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001104659-25-002584
Filing Date
2025-01-10
Accepted
2025-01-10 16:46:54
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRER14A | tm252001-2_prer14a.htm | PRER14A | 902724
2 | GRAPHIC | lg_cyclacel-4clr.jpg | GRAPHIC | 17219
3 | GRAPHIC | sg_jeffreywbullock-bw.jpg | GRAPHIC | 10632
4 | GRAPHIC | lg_secretarysoffistamp-bwlr.jpg | GRAPHIC | 13622
5 | GRAPHIC | px_cyclacel25pg01-4c.jpg | GRAPHIC | 309035
6 | GRAPHIC | px_cyclacel25pg02-4c.jpg | GRAPHIC | 169554
| Complete submission text file | 0001104659-25-002584.txt |  | 1585280

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 000-50626 | Film No.: 25523610
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)